Welcome to BioLab!

In 2004, we started at ULL a Phenotypic Drug Discovery (PDD) initiative whose goal is to use cell-based assays directed at the discovery of pharmacologically active small-molecules, trying to establish general bases for ultimately identifying their mechanism of action.

At BioLab we perform the biological evaluation of synthetic and natural compounds against a panel of representative human solid tumor cell lines. From this test, we determine if compounds are active and/or interesting to go into depth. We try to shed light on the mechanism of action by studying the effects of the products at a molecular level. Our ultimate goal is to identify the biological target(s) at which the active compound is directed. While the core activities of BioLab remain in this specific topic, in the past recent years we have expanded our capacities.